Target Price Playground
IBD
$23.10
Forward Projection
If price hits $26 by Jan 15
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Moderately bullish. Debit, capped max profit + loss.
๐ฏ Target
1-Click Institutional Target Anchors:
60d from today
โ๏ธ Legs
LONG CALL ยท $23 ยท Jan '27
Qty 1 ยท Premium $1.25 ยท ฮ 0.56
SHORT CALL ยท $25 ยท Jan '27
Qty 1 ยท Premium $0.5 ยท ฮ 0.3
P&L at Expiry
Stock (100 sh)
Bull Call Spread
Now
Target
๐ก Stock vs Options at Target
If IBD hits $26 by Jan 15: the bull call spread returns +$125 (165.2%) on $75 risked, vs +$277 (12.0%) for 100 shares on $2,310. Options give 13.8ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (60 days out). P&L shown is the value at expiry if IBD is at $26.
๐ Projected Return
P&L if IBD hits $26 by Jan 15
+$125
+165.2% on $75 risked
Max Profit
+$125
If the stock โฅ $25 at expiry
Max Loss
โ$75
Net debit
Break-even
$23.75
+2.83% from spot
Prob. of Profit at Expiry (PoP)
40.9%
Above breakeven ($23.75)
ยท Touch Target: 32%
30-Day Theta Burn (If Flat)
โ$5
6.6% of entry cost ยท Daily ฮ: $-0.18/day
Net ฮ / ฮ / V
26.38 / -0.18 / 0.44
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| IBD Price | Today | Dec 6 | Dec 26 | Jan 15 (exp) |
|---|---|---|---|---|
| $18 (-20%) | -$72 | -$74 | -$75 | -$75 |
| $20 (-15%) | -$65 | -$70 | -$74 | -$75 |
| $21 (-10%) | -$51 | -$59 | -$70 | -$75 |
| $22 (-5%) | -$28 | -$37 | -$52 | -$75 |
| $23 (-2%) | -$12 | -$19 | -$32 | -$75 |
| $23 (0%) โ spot | +$0 | -$5 | -$14 | -$65 |
| $24 (+2%) | +$12 | +$10 | +$5 | -$19 |
| $24 (+5%) | +$31 | +$33 | +$36 | +$51 |
| $25 (+10%) | +$59 | +$67 | +$80 | +$125 |
| $26 (+12%) โ target | +$69 | +$78 | +$93 | +$125 |
| $27 (+15%) | +$82 | +$92 | +$107 | +$125 |
| $28 (+20%) | +$99 | +$108 | +$119 | +$125 |
Uses IBD's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.